Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

By sjmartinez • January 3, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. PMID: 39748218.

Tags: Cabotegravir, HIV prevention, Infectious Diseases, long‐acting, pregnancy, PrEP, Publications, Women

Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers with childhood and adulthood exposures

Galetti SC, Gadoth A, Halbrook M, Tobin NH, Ferbas KG, Rimoin AW, Aldrovandi GM. Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers[...]

Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe[...]

Telemedicine for HIV care: a cross-sectional survey of people living with HIV receiving care at two federally qualified health centers in Los Angeles during a mature phase of the COVID-19 pandemic

Walker D, Moucheraud C, Butler D, Takayama C, Shoptaw S, Currier JS, Gladstein J, Hoffman R. Telemedicine for HIV care: a cross-sectional survey of people[...]